Sanofi SA
SAN: XPAR (FRA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| !r? | LOCK|%B&w | LOCK|$@?<vx^ |
Sanofi's New Leadership Faces Looming Patent Cliff
Business Strategy and Outlook
Sanofi's wide lineup of branded drugs and vaccines and robust pipeline creates strong cash flows and a narrow economic moat.
